The Student Biolab Mission
The Student Biolab is a platform and a community for students to design, prototype, and implement their life science research and product ideas.
We are a community of motivated students passionate about biotech, synbio, and all things biology, with a drive to do things ourselves. We operate our wet lab, where we run experimental workshops, build startup prototypes, and have fun with our community of students. We maintain close ties with academia and industry by organizing events with leaders in these fields.
Meet the Team
-
Timothy Kurer
President | iGEM Lead
UZH M.Sc. Neural Systems and Computation -
Sasha Melkonyan
Quästor | Biolab Space | iDEC
ETH M.Sc. CompBio | ex-Google engineer -
Flavio Rump
Vice-President
ETH M.Sc. ComBio | ex-Ginkgo -
Joseph Iwasyk
BioIncubate Lead
ETH M.Sc.; UPenn Alumnus | ex-AlphaThera -
Justyna Stefaniak
Marketing Lead
ETH PhD D-PHYS -
Larissa Bison
Community & Events Lead
UZH M.A. English and Biology -
Ivona Juric
Vice-Community & Events UZH M.Sc. Biology
-
Ekaterina Tocheva
Vice-Community & Events UZH B.Sc. Biomedicine
-
Julia Wyss
Vice-iGEM UZH B.Sc. BIomedicine
-
Oliver Nagl
Vice-Biolab Space
ETH B.Sc. Interdisciplinary Sciences -
Elina Jansone
Vice-Biolab Space ETH M.Sc. CompBio
-
Gabriel Cervera Arriaga
Vice-iDEC ETH M.Sc. Biology
-
Kian Bigovic Villi
Vice-iDEC ETH M.Sc.Biology
-
Kiran Kurinjirappalli
Vice-Quästor
UZH B.Sc. Medicine
Our Advisors
-
Dr. Ulrich Genick
ISMB, ETH
-
Lucie Rejman
Head of SPH | ETH
-
Prof. Dr. Markus Künzler
Prof. D-BIOL, ETH
-
Dr. Matthias Gstaiger
D-BIOL, ETH
Our Sponsor
CSEM is the first official sponsor of the Student Biolab. We greatly appreciate their support enabling our workshops, offering scientific expertise, & helping power the student impact from our lab space!
CSEM is a non-profit R&D company with locations throughout Switzerland, specializing in cutting-edge R&D. Their mission is to support the Swiss economy through R&D work & subsequent technology transfer, with a large focus in life sciences ranging from small startups to multinational pharmaceutical companies.
Partners
Statuten: Generalversammlung:
06.07.2023 Ausserordentliche GV 6.7.23